| 靶点: |
Insulin-like growth factor 2 mRNA binding protein (IGF2BP1) |
| 体内研究: |
AVJ16(100 mg/kg,腹腔注射,每两天一次,持续 3 周)在 LKR-M-FI 异种移植小鼠模型中表现出抗肿瘤活性。 |
| 参考文献: |
1. Singh A, et al. Development of a Novel IGF2BP1 Inhibitor as Metastasis-Specific Therapeutic Agent[J]. European Journal of Cancer, 2022, 174: S104-S105.2. Wallis N, et al. AVJ16 inhibits the RNA binding protein IGF2BP1 in lung adenocarcinomas and prevents tumor growth in mice[J]. bioRxiv, 2024: 2024.08. 15.608038. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.13 ml |
10.649 ml |
21.298 ml |
| 5 mM |
0.426 ml |
2.13 ml |
4.26 ml |
| 10 mM |
0.213 ml |
1.065 ml |
2.13 ml |
| 50 mM |
0.043 ml |
0.213 ml |
0.426 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |